FDA PMA FDA Class 3 Approved 🇺🇸 United States

Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction

PMA: P000058 · Supplement: S005 · Decision Dec 27, 2004
Classifications
1
FEI Numbers
6
Registration Numbers
6

Basic Information

Device Name
Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction
Trade Name
INFUSE BONE GRAFT/LT-CAGE LUMBAR TAPERED FUSION DEVICE
PMA Number
P000058
Supplement Number
S005
Device Class
FDA Class 3
Product Code
NEK
Generic Name
Filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction
Medical Specialty
Unknown
Advisory Committee
Orthopedic
Decision
Approved
Decision Code
APPR
Decision Date
December 27, 2004
Date Received
August 22, 2003
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Postapproval Study Protocol
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR THE DRAFT PROTOCOL FOR THE RABBIT REPRO/TOX STUDY REQUIRED AS A CONDITIONS OF APPROVAL. THE PROPOSED STUDY IS DESIGNED TO EVALUATE THE IMPACT OF A MATERNAL IMMUNE RESPONSE ON THE DEVELOPMENT OF OFFSPRING. THIS IS DETERMINED VIA AN ASSESSMENT OF "ETAL MORTALITY, FETAL WEIGHT, AND FETAL PLACENTAL MORPHOLOGY

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NEK Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction